Quality of life in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin.
Anne-Kathrine RyltoftAli Al-ZuhairySøren Hein SindrupHenning AndersenLars K MarkvardsenPublished in: Acta neurologica Scandinavica (2020)
In SCIG treated CIDP patients QoL is reduced and correlates to gait performance and disability.